The serotonin-catecholamine-dream bicycle: a clinical study.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000368:Aged; D001921:Brain / Q000502:physiology; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism*; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004325:Dreams; D004569:Electroencephalography; D005260:Female; D010134:Fenclonine / Q000494:pharmacology; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000378:metabolism; D008875:Middle Aged; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D010649:Phenylalanine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism*; D012890:Sleep / Q000187:drug effects; D012895:Sleep, REM / Q000187:drug effects; D014364:Tryptophan / Q000494:pharmacology; D014443:Tyrosine / Q000494:pharmacology; D014446:Tyrosine 3-Monooxygenase / Q000037:antagonists & inhibitors
D002395:Catecholamines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D014443:Tyrosine; D010649:Phenylalanine; D004295:Dihydroxyphenylalanine; D014364:Tryptophan; D006916:5-Hydroxytryptophan; D014446:Tyrosine 3-Monooxygenase; D010134:Fenclonine